cyclopentane has been researched along with dinoprostone in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baertschi, SW; Brash, AR; Harris, TM; Ingram, CD | 1 |
| Egashira, H; Harada, H; Ishida, A; Kondo, K; Maruyama, T; Naganawa, A; Nakai, H; Ogawa, M; Ohuchida, S; Sagawa, K; Tani, K; Toda, M | 1 |
| Balsamo, A; Coletta, I; Guglielmotti, A; Landolfi, C; Lapucci, A; Mancini, F; Milanese, C; Minutolo, F; Orlandini, E; Ortore, G; Pinza, M; Rapposelli, S | 1 |
| Balsamo, A; Coletta, I; Guglielmotti, A; Landolfi, C; Mancini, F; Martinelli, A; Milanese, C; Minutolo, F; Nencetti, S; Orlandini, E; Pinza, M; Rapposelli, S; Rossello, A | 1 |
| Masuko-Hongo, K | 1 |
| Kondo, K; Nakao, W; Nozawa, H; Zhao, F | 1 |
| Boyen, C; Gaquerel, E; Hervé, C; Labrière, C; Potin, P; Salaün, JP | 1 |
| Jang, SK; Kim, JH; Kim, WJ | 1 |
| Bland, JS; Carroll, B; Darland, G; Hall, A; Katke, J; Lamb, J; Lerman, RH; Minich, DM; Tripp, M | 1 |
| Austin, M; Bland, JS; Carroll, BJ; Darland, G; Desai, A; Konda, VR; Prabhu, KS; Tripp, ML | 1 |
| Senthil Kumar, KJ; Wang, SY | 1 |
| Belvisi, MG; Birrell, MA; Maher, SA | 1 |
| Hsieh, HW; Senthil Kumar, KJ; Wang, SY | 1 |
| Fröhlich, E; Gattenlöhner, S; Heinemann, A; Konya, V; Lang-Loidolt, D; Lippe, IT; Luschnig-Schratl, P; Marsche, G; Peskar, BA; Philipose, S; Samberger, C; Schuligoi, R; Sturm, EM | 1 |
| Beltrán, J; Correa, J; Delage, L; Faugeron, S; Flores, V; Kloareg, B; Lion, U; Pohnert, G; Potin, P; Weinberger, F | 1 |
| Bálint, Z; Heinemann, A; Konya, V; Marsche, G; Olschewski, A; Peskar, BA; Philipose, S; Schicho, R; Schuligoi, R; Sturm, EM | 1 |
| Hasegawa, I; Ohta, T; Zhang, L | 1 |
| An, HJ; Choi, YH; Hyun, CG; Kim, MJ; Kim, SS; Lee, NH; Park, KJ | 1 |
| Gunjegaonkar, SM; Shanmugarajan, TS | 1 |
1 review(s) available for cyclopentane and dinoprostone
| Article | Year |
|---|---|
[Role of prostaglandins in rheumatoid arthritis].
Topics: Animals; Apoptosis; Arthritis, Rheumatoid; Cartilage, Articular; Cyclopentanes; Dinoprostone; Humans; Inflammation Mediators; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Synovial Membrane | 2005 |
1 trial(s) available for cyclopentane and dinoprostone
| Article | Year |
|---|---|
Clinical safety and efficacy of NG440: a novel combination of rho iso-alpha acids from hops, rosemary, and oleanolic acid for inflammatory conditions.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Cell Count; Blood Coagulation; Blood Pressure; Cells, Cultured; Cross-Over Studies; Cyclopentanes; Dinoprostone; Double-Blind Method; Drug Combinations; Feces; Female; Humans; Humulus; Kidney Function Tests; Leukocyte L1 Antigen Complex; Liver Function Tests; Male; Mice; Naproxen; Oleanolic Acid; Pain; Plant Extracts; Rheumatic Diseases; Rosmarinus | 2007 |
17 other study(ies) available for cyclopentane and dinoprostone
| Article | Year |
|---|---|
Allene oxides as intermediates in biosynthesis of ketols and cyclopentenones.
Topics: Alkadienes; Animals; Cyclopentanes; Dinoprostone; Hydroxy Acids; Keto Acids; Lipoxygenase; Mollusca; Oxides; Plants | 1989 |
Design and synthesis of a highly selective EP2-receptor agonist.
Topics: Alprostadil; Animals; Binding Sites; CHO Cells; Cricetinae; Cyclic AMP; Cyclobutanes; Cyclopentanes; Dinoprostone; Drug Design; Female; Humans; Ligands; Mice; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Sensitivity and Specificity; Uterine Contraction | 2001 |
Aryl-substituted methyleneaminoxymethyl (MAOM) analogues of diarylcyclopentenyl cyclooxygenase-2 inhibitors: effects of some structural modifications on their biological properties.
Topics: Administration, Oral; Animals; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cyclopentanes; Dinoprostone; Edema; Humans; Inflammation; Inhibitory Concentration 50; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Structure-Activity Relationship; U937 Cells | 2002 |
Synthesis of heteroaromatic analogues of (2-aryl-1-cyclopentenyl-1-alkylidene)-(arylmethyloxy)amine COX-2 inhibitors: effects on the inhibitory activity of the replacement of the cyclopentene central core with pyrazole, thiophene or isoxazole ring.
Topics: Amines; Animals; Binding Sites; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cyclopentanes; Dinoprostone; Humans; Isoenzymes; Isoxazoles; Macrophages; Membrane Proteins; Mice; Models, Molecular; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Structure-Activity Relationship; Thiophenes; U937 Cells | 2003 |
Dietary supplement of isohumulones inhibits the formation of aberrant crypt foci with a concomitant decrease in prostaglandin E2 level in rat colon.
Topics: Animals; Azoxymethane; Beer; Carcinogens; Cell Line; Colon; Colonic Neoplasms; Cyclopentanes; Dietary Supplements; Dinoprostone; Interferon-gamma; Intestinal Mucosa; Ionophores; Lipopolysaccharides; Macrophages; Male; Mice; Precancerous Conditions; Rats; Rats, Inbred F344 | 2005 |
Evidence for oxylipin synthesis and induction of a new polyunsaturated fatty acid hydroxylase activity in Chondrus crispus in response to methyljasmonate.
Topics: Acetates; Algal Proteins; Chondrus; Cyclopentanes; Dinoprostone; DNA Primers; Fatty Acids, Unsaturated; Gas Chromatography-Mass Spectrometry; Kinetics; Linoleic Acid; Mixed Function Oxygenases; Oxylipins; Polymerase Chain Reaction; Prostaglandins A; RNA; Substrate Specificity | 2007 |
Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A.
Topics: Anti-Inflammatory Agents; Arachidonic Acid; Arsenites; Chromans; Cyclopentanes; Cytoplasmic Granules; Dinoprostone; Emetine; Enzyme Inhibitors; Eukaryotic Initiation Factor-2; Eukaryotic Initiation Factor-4A; Gene Expression Regulation; HeLa Cells; Humans; Hypoglycemic Agents; Inflammation; Poly(A)-Binding Proteins; PPAR gamma; Prostaglandin D2; Prostaglandins A; Protein Biosynthesis; Protein Synthesis Inhibitors; Rosiglitazone; Signal Transduction; Sodium Compounds; T-Cell Intracellular Antigen-1; Thiazolidinediones; TNF Receptor-Associated Factor 2; Troglitazone; Tumor Necrosis Factor-alpha | 2007 |
META060 inhibits multiple kinases in the NF-kappaB pathway and suppresses LPS--mediated inflammation in vitro and ex vivo.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cyclooxygenase 2; Cyclopentanes; Dinoprostone; Humans; Inflammation; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; Molecular Structure; NF-kappa B; Nitric Oxide; Protein Kinase Inhibitors; Signal Transduction; Tumor Necrosis Factor-alpha | 2009 |
Lucidone inhibits iNOS and COX-2 expression in LPS-induced RAW 264.7 murine macrophage cells via NF-kappaB and MAPKs signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Cell Culture Techniques; Cyclooxygenase 2 Inhibitors; Cyclopentanes; Dinoprostone; Gene Expression; JNK Mitogen-Activated Protein Kinases; Lindera; Lipopolysaccharides; Macrophages; Male; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; NF-kappa B p50 Subunit; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Protein Transport; RNA, Messenger; Signal Transduction; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2009 |
Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy.
Topics: Animals; Benzofurans; Cough; Cyclopentanes; Dimethyl Sulfoxide; Dinoprostone; Guinea Pigs; Humans; In Vitro Techniques; Isoindoles; Male; Mice; Mice, Inbred C57BL; Propionates; Pyridines; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Sensory Receptor Cells; Sulfonamides; Vagus Nerve; Xanthones | 2009 |
Anti-inflammatory effect of lucidone in mice via inhibition of NF-kappaB/MAP kinase pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Blotting, Western; Cyclooxygenase 2 Inhibitors; Cyclopentanes; Dinoprostone; Electrophoretic Mobility Shift Assay; I-kappa B Kinase; Inflammation; Lindera; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2010 |
EP4 receptor stimulation down-regulates human eosinophil function.
Topics: Calcium; Calcium Channels; CD11b Antigen; Cell Movement; Cyclopentanes; Dinoprostone; Down-Regulation; Eosinophils; Humans; Inflammation; Isoindoles; Methyl Ethers; Nasal Mucosa; Phosphatidylinositol 3-Kinases; Protein Kinase C; Protein Kinase Inhibitors; Reactive Oxygen Species; Receptors, Prostaglandin E, EP4 Subtype; Sulfonamides; Thioglycolates | 2011 |
Up-regulation of lipoxygenase, phospholipase, and oxylipin-production in the induced chemical defense of the red alga Gracilaria chilensis against epiphytes.
Topics: Cyclopentanes; Dinoprostone; Gracilaria; Lipoxygenase; Oxylipins; Phospholipases A; Plant Growth Regulators; Plant Immunity; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2011 |
Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptors.
Topics: CD18 Antigens; Cell Adhesion; Cell Communication; Cell Line; Cell Movement; Cells, Cultured; Chemokine CCL11; Cyclopentanes; Dinoprostone; Endothelial Cells; Eosinophils; Fibronectins; Flow Cytometry; Gelsolin; Humans; L-Selectin; Methyl Ethers; Microscopy, Confocal; Naphthalenes; Phenylbutyrates; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Thioglycolates; Thrombin; Tumor Necrosis Factor-alpha | 2011 |
Anti-inflammatory cyclopentene derivatives from the inner bark of Tabebuia avellanedae.
Topics: Animals; Anti-Inflammatory Agents; Benzoates; Cyclopentanes; Dinoprostone; Esters; Mice; Nitric Oxide; Plant Bark; Plant Extracts; RAW 264.7 Cells; Tabebuia | 2016 |
Methyl jasmonate inhibits lipopolysaccharide-induced inflammatory cytokine production via mitogen-activated protein kinase and nuclear factor-κB pathways in RAW 264.7 cells.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Cyclooxygenase 2; Cyclopentanes; Cytokines; Dinoprostone; Inflammation; Inflammation Mediators; Lipopolysaccharides; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Oxylipins; Plant Growth Regulators; RAW 264.7 Cells | 2016 |
Methyl jasmonate a stress phytohormone attenuates LPS induced in vivo and in vitro arthritis.
Topics: Acetates; Animals; Arthritis; Behavior, Animal; Chondrocytes; Cold Temperature; Cyclooxygenase 2; Cyclopentanes; Dinoprostone; Hyperalgesia; Interleukin-2; Lipopolysaccharides; Male; Matrix Metalloproteinases; Nitric Oxide; Oxylipins; Pancreatic Elastase; Peptide Hydrolases; Peroxidase; Plant Growth Regulators; Rats, Wistar; Stress, Physiological; Tail; Tumor Necrosis Factor-alpha | 2019 |